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Schistosomes, a class of parasitic trematode worms, cause schistosomiasis.
Accumulating evidence suggests that microRNAs (miRNAs)—small, non-coding RNAs
that are known to play critical regulatory roles in many organisms—may be involved
in schistosome development and sexual maturation, as well as the pathogenesis of
schistosomiasis. Schistosoma miRNAs, such as Bantam and miR-10, may be involved
in the pathological processes of schistosomiasis, and recent studies suggest that
schistosome-specific miRNAs (e.g., Bantam, miR-3479-3p) in the bloodstream of a final
host could be used as biomarkers for schistosomiasis diagnosis. Furthermore, aberrant
miRNAs, such as miR-223 and miR-454, can be produced by a host in response
to schistosome infection, and these miRNAs may contribute to the pathogenesis of
schistosomiasis-associated liver injury. Here, we summarize recent progress evaluating
the relationship between schistosome miRNAs and schistosomiasis and discuss how
these miRNAs can mediate the pathogenesis of schistosomiasis and be used as
biomarkers for schistosomiasis diagnosis.
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INTRODUCTION
Schistosomiasis is a parasitic disease found worldwide and is
caused primarily by worms of the genus Schistosoma. The main
disease-causing species are S. haematobium, S. mansoni, and
S. japonicum. Over 200 million people are infected with this par-
asite worldwide, leading to 300,000 deaths annually, mostly in
the developing world (Colley et al., 2014). In China, schistoso-
miasis japonica is a serious public health problem (Zhou et al.,
2005a,b). Unfortunately, there is no available vaccine for schis-
tosomiasis. Praziquantel is the only drug that is widely used to
treat schistosomiasis, but it is ineffective in preventing reinfection
and there are concerns regarding the development of praziquantel
resistance following large-scale and repeated use (Bergquist et al.,
2008; Wang et al., 2012b). Consequently, a deeper understanding
of the mechanisms of schistosome development and the patho-
genesis of schistosomiasis may aid in the development of novel
strategies to control this disease.
MicroRNAs (miRNAs), a class of small non-coding RNAs,
can regulate a wide range of pivotal biological processes
such as development, cell proliferation and differentiation, cell
death, metabolism, and signal transduction in many organisms
(Ambros, 2003; Carrington and Ambros, 2003; Miska, 2005).
Schistosomes have a complex developmental cycle with diverse
life stages, which suggests that gene expression in these organ-
isms is regulated accurately and precisely (Gomes et al., 2009;
Zhou et al., 2009; De Souza Gomes et al., 2011). Since miRNAs
act as critical post-transcriptional regulators in many organisms,
studies have been actively carried out to determine the role miR-
NAs play in schistosomes. These studies support our notion that
miRNAs could be important regulators for schistosome devel-
opment and potential therapeutic targets against schistosomiasis
(Cheng and Jin, 2012). In addition, recent findings have provided
new information regarding the roles of miRNAs in schistosome
development and the pathogenesis of schistosomiasis. Here, we
summarize recent research evaluating miRNAs in schistosomes
and explore how schistosome miRNAs can serve as mediators of
the pathogenesis of schistosomiasis. In addition, we also discuss
the use of miRNAs as biomarkers for schistosomiasis diagnosis.
IDENTIFICATION OF SCHISTOSOME miRNAs
To date, 79 mature miRNAs in S. japonicum and 225 mature miR-
NAs in S. mansoni have been documented in miRBase (Version
21). Although schistosome miRNAs have been summarized pre-
viously (Cheng and Jin, 2012), recent research has further investi-
gated miRNA profiles in schistosomes, the results of these studies
are summarized in Table 1.
Briefly, miRNA profiles at several stages of S. japonicum
development have been characterized; miRNAs present in lung-
stage schistosomula, hepatic-stage schistosomula, adult males,
adult females, and eggs of this species were documented, and
199 novel miRNAs with stage specificities were found (Cai
et al., 2011). Additional research evaluating miRNA profiles
in S. japonicum eggs have indicated that sja-miR-71b-5p, sja-
miR-71, sja-miR-1, sja-miR-36-3p, and sja-miR-124-3p were the
most abundant miRNAs at this developmental stage (Cai et al.,
2013a). Concurrent with research in S. japonicum, 112 miR-
NAs (including 84 novel miRNA families) were reported in adult
worms of S. mansoni (Marco et al., 2013). Among them, 26
miRNAs were shown to be conserved in other flatworms such
as Schmidtea mediterranea and Dugesia japonica (Marco et al.,
2013). In addition, a more recent study reported a total of
2258 miRNAs identified in S. japonicum collected from single-
and double-sex infected mice (Sun et al., 2014); however, the
authors did not provide information about the number of
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Table 1 | Updated list of miRNAs identified in schistosomes.
Species Conserved miRNAs Species-specific miRNAs Stages Methods References
S. japonicum 65 213 L, H, M, F, E Deep sequencing, Northern
blotting, qRT-PCR
Cai et al., 2011
4 1 A Deep sequencing, qRT-PCR,
semi-quantitative RT-PCR
Cheng et al., 2013
S. mansoni 61 48 – Bioinformatics De Souza Gomes et al., 2011
26 71 A Deep sequencing Marco et al., 2013
A, adult worms (mixed males and females); L, lung-stage schistosomula; F, adult females; E, eggs; H, hepatic schistosomula; M, adult males.
evolutionary conserved miRNAs. Moreover, in our recent work,
five pathogen-specific miRNAs were identified in the plasma of
rabbits infected with S. japonicum, including four known miR-
NAs (Bantam, miR-3479, miR-10, and miR-3096), and one novel
miRNA (sja-miR-8185) (Cheng et al., 2013).
On comparing these known miRNAs across the
Platyhelminthes, most were found to be conserved (Jin et al.,
2013). In addition, some S. japonicum miRNAs (e.g., miR-1b,
miR-124, miR-190, et al.) also displayed evolutionary conserva-
tion among Homo sapiens, Mus musculus, Caenorhabditis elegans,
and Drosophila melanogaster (Cheng and Jin, 2012).
POTENTIAL ROLE OF SCHISTOSOMA miRNAs IN WORM
DEVELOPMENT AND THE PATHOGENESIS OF
SCHISTOSOMIASIS
Different stages of schistosome development are associated with
different categories of miRNAs, suggesting that miRNAs may be
involved in the regulation of schistosome development (Krautz-
Peterson and Skelly, 2008; Xue et al., 2008; Chen et al., 2010; Hao
et al., 2010; Luo et al., 2010; Cai et al., 2011; Simoes et al., 2011).
Several lines of evidence also indirectly imply that miRNAs may
regulate the pathogenesis of schistosomiasis (Cheng et al., 2013;
Hoy et al., 2014).
First, the key components of miRNA biogenesis, includ-
ing the Ago proteins (Chen et al., 2010) and Dicer (Krautz-
Peterson and Skelly, 2008; Luo et al., 2010), have been shown
to be differentially expressed during different stages of schis-
tosome development. Second, some of miRNAs such as miR-
36, miR-71, bantam, miR-7, and others, have been shown to
specifically express in a specific stage of S. japonicum (Xue
et al., 2008; Hao et al., 2010; Cai et al., 2011). In addition,
the similar phenomenon was also observed in S. mansoni (miR-
4, miR-6, miR-9, miR-32, miR-125, miR-3, and miR-5 were
expressed in adult worms only, and miR-20, miR-18, miR-22,
miR-26, and bantam were expressed in schistosomula only)
(Simoes et al., 2011). Third, bioinformatic analyses have indicated
that several evolutionarily conserved miRNAs (miR-8, miR-1,
miR-124, miR-71, and miR-195) in schistosomes may regu-
late phylogenetically conserved mRNA targets (Cheng and Jin,
2012); however, experimental confirmation of these results is
needed.
Besides role of miRNAs in schistosome development, recent
work within our laboratory implies that schistosome-derived
miRNAs may regulate the pathogenesis of schistosomiasis within
a final host (Cheng et al., 2013). In this study, we identified
Schistosoma-specific Bantam miRNA within plasma derived from
a host infected with S. japonicum. In Drosophila, it has been
shown that Bantam can target a tumor-suppressor pathway, and
that overexpression of Bantam led to cellular growth and the sup-
pression of cellular death (Nolo et al., 2006). In addition, it was
reported that human schistosomiasis is associated with increased
risks for bladder (S. haematobium) and liver (S. mansoni, S. japon-
icum) cancers (Takemura et al., 1998; Gryseels et al., 2006). Given
this research, we hypothesized that schistosome-specific miRNAs,
such as Bantam, may be involved in the etiology of cancers in
a host infected with schistosomes (Figure 1); however, further
studies will need to be carried out to test this hypothesis.
ROLE OF HOST miRNAs IN THE PATHOGENESIS OF
SCHISTOSOMIASIS
In addition to schistosome-derived miRNAs, recent studies also
suggest that host miRNAs may be involved in regulating the
pathogenesis of schistosomiasis (Figure 1). Integrative analysis
of miRNA and mRNA profiles in murine liver suggested that
miRNAs, and their corresponding mRNA targets, may function
coordinately to regulate the hepatic pathology of a host during
schistosome infection (Cai et al., 2013b). Furthermore, miRNA
profiles in different tissues (liver, spleen, and lung) of S. japon-
icum-infected mice implied that miRNAs may be involved in
the regulation of several signaling pathways—such as the MAPK,
insulin, Toll-like receptor, and TGF-β pathways—during schis-
tosome infection (Han et al., 2013). In a recent study, miR-223
was primarily found in Kupffer cells in the liver, and the expres-
sion of this miRNA was dramatically elevated in liver cells of
schistosome-infected mice (He et al., 2013); it is possible that the
expression levels of miR-223 could reflect the extent of patholog-
ical changes in the liver of an infected host. Moreover, miR-454,
a target miRNA of Smad4, was found to be down-regulated in
S. japonicum-induced murine liver fibrosis models, while α-SMA
and Smad4 were up-regulated (Zhu et al., 2014); these results sug-
gested that the down-regulation of miR-454 may be involved in
the pathogenesis of liver fibrosis in S. japonicum-infected mice.
Despite these findings, the functions of miR-223 and miR-454
need to be further investigated at different biological levels, in
order to fully understand the roles that these miRNAs play in the
pathogenesis of schistosomiasis.
Since certain miRNAs have been shown to potentially play an
important role in the pathogenesis of schistosomiasis, the usage
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FIGURE 1 | Summary of the roles of miRNAs in the pathogenesis of schistosomiasis. Parasite activities are depicted in red, and host activities are
depicted in blue. The solid lines indicate the proven biological effects of miRNAs, and the dotted lines indicate their putative effects.
of the antisense technology blocking specific miRNAs and/or an
augment method for improving the expressions of some miRNAs
may have a potential to provide alternative strategies for schis-
tosomiasis control as optimism have been demonstrated from
miRNA-based anti-tumor therapy (Krutzfeldt et al., 2005; Ma
et al., 2010; Wang et al., 2012a).
ROLE OF miRNAs IN SCHISTOSOMIASIS DIAGNOSIS
Early diagnosis of schistosomiasis is critical to control this dis-
ease. However, no reliable biomarker exists for early diagnosis of
schistosomiasis. Circulating miRNAs, which are present in a sta-
ble form in the plasma or serum of an infected host, have been
considered ideal biomarkers for the diagnosis of some cancers.
It is possible that such circulating miRNAs could also serve as
biomarkers for schistosomiasis diagnosis.
As mentioned above, five pathogen-specificmiRNAs in the cir-
culation of a S. japonicum-infected host were identified in our
study and the subsequent validation study indicated that there is a
correlation between the abundance of schistosome-specific miR-
NAs in the plasma of schistosome-infected mice and the number
of S. japonicum cercariae in the inoculum (Cheng et al., 2013).
More recently, eleven schistosome-specific miRNAs were identi-
fied in mice infected with S. mansoni (Hoy et al., 2014); three
of these parasite-derived miRNAs (Bantam, miR-3479-3p, and
miR-277) may be potential biomarkers for schistosomiasis diag-
nosis. Similarly, we detected three miRNAs (Bantam, miR-3479,
and miR-10) in the plasma of mice infected with S. japon-
icum (Cheng et al., 2013). Collectively, these results suggest that
parasite-specific miRNAs in the circulation of a host may be
potential biomarkers for schistosomiasis diagnosis. However, it
remains to be determined whether this kind of pathogen spe-
cific circulating miRNAs is associated with specific species in
schistosomes.
Apart from Schistosoma-specific miRNAs, aberrant host miR-
NAs associated with schistosome infection may also be potential
indicators of schistosomiasis. A recent study indicated that miR-
223 was significantly up-regulated in the serum of mice infected
with S. japonicum and returned to near normal levels on prazi-
quantel treatment (He et al., 2013), implying that up-regulated
murine miR-223 may be a biomarker for Schistosoma infection.
However, the possibility that altered serum levels of miR-223 are
caused by other diseases or the pathogenesis of other organs needs
to be assessed.
Currently, circulating miRNA detection mostly relies on qRT-
PCR (Cheng, 2014). Additionally, several recent studies also
documented that the sensitivity of miRNA detection could be sig-
nificantly improved by using novel target miRNA amplification
methods such as RAKE assay (Nelson et al., 2004), rolling-circle
amplification (Cheng et al., 2009), and DNA concatamers-based
amplification (Hong et al., 2013) and also the combination of new
signal detection techniques including a total internal reflection
fluorescence microscope (Ho et al., 2014) or an electrochemical
device (Hong et al., 2013; Ren et al., 2013). In future, it may be
necessary to evaluate these methods for schistosomiasis diagnosis
by detecting circulating miRNAs.
SUMMARY
Recent studies have indicated that miRNAs play important roles
in schistosome development and their parasitism. Although
analyses of miRNA profiles have provided valuable informa-
tion regarding the mechanisms underlying the pathogenesis of
schistosomiasis, and suggested potential novel applications in
diagnostics, our current understanding of these molecular mech-
anisms remains limited. Consequently, it is necessary to charac-
terize the functions of schistosome-specific miRNAs and clarify
their potential as diagnostic markers for schistosomiasis. Since
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miRNAs exert their effect by targeting protein-encoding mRNAs,
verifying miRNA targets in both hosts and parasites is essential
for understanding the mechanisms of host-parasite interactions,
and developing novel therapeutic agents for schistosomiasis.
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